Image-01-hydralazine-structural-formula (Image 01 Hydralazine Structural Formula)
Hydralazine Hydrochloride Injection
Product Images NDC 43066-041
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 43066-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-02-container-label (Image 02 Container Label)
This text provides information about the medication with the NDC code 43066-041-01, which is for intravenous use. It includes details on storage conditions (20°C to 25°C) and the usual dosage of 20 mg/mL for hydralazine hydrochloride. The medication is in a 1mL single-dose vial manufactured by Baxter Healthcare Corporation in the USA. It is indicated for intramuscular or injections.*
Image-03-carton-label-01 (Image 03 Carton Label 01)
This text is a detailed description of Hydralazine Hydrochloride Injection. It states the active ingredient, Hydralazine hydrochloride USP, 20 mg per mL, along with the inactive components propylene glycol USP and water for injection. The solution has a pH range of 3.4 to 4.0 and includes preservatives: Methylparaben NF and Propylparaben NF. It is intended for emergency use in patients who are unable to take oral medications, and can be administered intramuscularly or intravenously. The drug is presented in single-dose vials containing 1 mL each.*
Image-04-carton-label-02 (Image 04 Carton Label 02)
This is a description of a pharmaceutical product labeled as hydrochloride injection for intramuscular or intravenous use. It comes in single-dose vials and is manufactured by Baxter. The usual dosage information is included in the package insert, and storage instructions recommend keeping it at 20°C to 25°C. The product is sterile and nonpyrogenic. Unused portions should be discarded. Additional details may be available for production purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
